Join the $1K to $100K Trading Challenge! - https://bit.ly/1kto100ktradingchallenge
2 extracted signals · 1 resolved · 1 still active
Altcoin Doctor13 Oct 2025, 13:04 UTC
AI-generated source summary
The video presents a technical analysis of the cryptocurrency Kaspa (KASUSDT) and Bitcoin dominance (BTC.D). The analysis suggests Kaspa is in a Wyckoff accumulation schematic, phase C, and predicts a subsequent move towards 0.14418. A failure of the analysis to proceed as predicted would occur if it reaches price of 0.04, invalidating the bullish outlook. Bitcoin Dominance shows a rising trend with a fake out to push to the upside. The macrodata trend is bearish with a target of 40.00 at 2026. The analysis uses a weekly timeframe for both cryptocurrency pairs. The presenter also reviews the USDT dominance trend and expects it to go further down in price, noting an inverse relationship with the cryptocurrency markets.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
2 eligible signals linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Live evaluation in progress
1 signal remains active.
Signals in this source
More Prediction Case Files from Altcoin Doctor
SUI - THE EXPONENTIAL BLOCK - SUI Price Prediction
SOLANA - THE EXPONENTIAL BLOCK - SOLANA Price Prediction
RENDER - THE EXPONENTIAL BLOCK - RENDER Price Prediction
NEAR - THE EXPONENTIAL BLOCK - NEAR Price Prediction
AAVE - THE EXPONENTIAL BLOCK - AAVE Price Prediction
VECHAIN - THE EXPONENTIAL BLOCK - VET Price Prediction
Altcoin Doctor
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

